040-27818822 info@waterley.co.in
  • facebook
  • linkedin
  • facebook
  • linkedin
Waterley
  • Home
  • About
    • Overview
    • Milestones
    • Management
  • New Products
  • News Update
  • Careers
  • Contact
  • Employee Login
Select Page

Insulin Resistance: A Key Predictor of NAFLD in Lean Patients

by Waterley Pharma | Nov 15, 2023 | News Updates

Introduction: Insulin resistance has emerged as a crucial factor in predicting the development of NAFLD (Non-alcoholic fatty liver disease) among lean individuals, as highlighted in a recent study. This groundbreaking research, presented at the ACG 2023 Annual...

Latest Updates

  • Insulin Resistance: A Key Predictor of NAFLD in Lean Patients
  • Belching, Abdominal Bloating, and Distention: Latest Recommendations for Evaluation and Management
  • Mean Platelet Volume (MPV) – A Simple Test for Nonalcoholic Fatty Liver Disease (NAFLD)
  • facebook
  • linkedin

Copyright © 2025 Waterley Pharmaceuticals Pvt. Ltd.